Showing 1 - 20 results of 30,852 for search '(( 5 ppm decrease ) OR ((( 15 ((_ decrease) OR (a decrease)) ) OR ( 5 nm decrease ))))', query time: 1.03s Refine Results
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6

    Mean decrease in accuracy (MDA) of top 15 urine metabolites. by Liam E. Broughton-Neiswanger (8447220)

    Published 2020
    “…Urine metabolites with a mean decrease in accuracy ≥ 0.004 in at least one post-treatment time point (2–5) were considered for inclusion in the predictive model.…”
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12

    Top 15 predictors in the ML model for IHD based on mean decrease accuracy. by N. Salet (19173000)

    Published 2024
    “…<p>Top 15 predictors in the ML model for IHD based on mean decrease accuracy.…”
  13. 13

    Top 15 predictors in the ML model for AMI based on mean decrease accuracy. by N. Salet (19173000)

    Published 2024
    “…<p>Top 15 predictors in the ML model for AMI based on mean decrease accuracy.…”
  14. 14
  15. 15

    Discovery of the Triazolo[1,5‑<i>a</i>]Pyrimidine-Based Derivative WS-898 as a Highly Efficacious and Orally Bioavailable ABCB1 Inhibitor Capable of Overcoming Multidrug Resistance... by Shuai Wang (109515)

    Published 2021
    “…Here, we reported our medicinal chemistry efforts that led to the discovery of the triazolo­[1,5-<i>a</i>]­pyrimidine derivative <b>WS-898</b> as a highly effective ABCB1 inhibitor capable of reversing paclitaxel (PTX) resistance in drug-resistant SW620/Ad300, KB-C2, and HEK293/ABCB1 cells (IC<sub>50</sub> = 5.0, 3.67, and 3.68 nM, respectively), more potent than verapamil and zosuquidar. …”
  16. 16

    Discovery of the Triazolo[1,5‑<i>a</i>]Pyrimidine-Based Derivative WS-898 as a Highly Efficacious and Orally Bioavailable ABCB1 Inhibitor Capable of Overcoming Multidrug Resistance... by Shuai Wang (109515)

    Published 2021
    “…Here, we reported our medicinal chemistry efforts that led to the discovery of the triazolo­[1,5-<i>a</i>]­pyrimidine derivative <b>WS-898</b> as a highly effective ABCB1 inhibitor capable of reversing paclitaxel (PTX) resistance in drug-resistant SW620/Ad300, KB-C2, and HEK293/ABCB1 cells (IC<sub>50</sub> = 5.0, 3.67, and 3.68 nM, respectively), more potent than verapamil and zosuquidar. …”
  17. 17
  18. 18
  19. 19
  20. 20